Similar to its effect on Wnt1 tumours, Canertinib showed a pronounced anti-migratory affect in TUBO tumours with no migratory colonies visible in 100% of samples regardless of adipocyte status (Fig. 7b,e–g). This evidence concerns the gene WNT1 and neoplasm.